<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Treatment of intracranial atherosclerotic disease with the Wingspan-Gateway intracranial stent and balloon angioplasty system has been reported in several multicenter registries </plain></SENT>
<SENT sid="1" pm="."><plain>To date, the incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> intraprocedural <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation during Wingspan stent placement has not been reported </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: We reviewed the incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation, treatment, and outcome for patients who underwent Wingspan stent placement by the senior author (B.L.H.) between June 2006 and April 2009 </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We routinely perform angiograms every 10 minutes for at least 30 minutes after placement of a Wingspan stent to check for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was graded: (1) visible <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> but not flow limiting, (2) visible and flow-limiting <z:mp ids='MP_0005048'>thrombosis</z:mp>, and (3) complete stent occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>Recanalization was graded according to <z:mp ids='MP_0005048'>Thrombosis</z:mp> In <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> score </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Forty-one patients underwent Wingspan stent placement for intracranial stenosis </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> intraprocedural <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation developed in 6 (14.6%) within 20 minutes after stent placement: 3 grade 1, 1 grade 2, and 2 grade 3 </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 6 were successfully recanalized with <z:mp ids='MP_0005048'>Thrombosis</z:mp> In <z:hpo ids='HP_0001658'>Myocardial Infarction</z:hpo> score 3 after intravenous abciximab with or without intra-arterial tissue plasminogen activator and/or balloon angioplasty </plain></SENT>
<SENT sid="9" pm="."><plain>There was no morbidity, and <z:hpo ids='HP_0000001'>all</z:hpo> 6 patients were discharged home at their neurological baseline </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: We recommend serial angiography every 10 minutes for at least 30 minutes after placement of Wingspan stents </plain></SENT>
<SENT sid="11" pm="."><plain>Once detected, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0005048'>thrombosis</z:mp> can be successfully treated with intravenous abciximab with or without intra-arterial tissue plasminogen activator and/or balloon angioplasty </plain></SENT>
</text></document>